Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve unaudited financial results (standalone) of the Company for the quarter ended on June 30, 2026.
